Enrolling patients in ongoing randomized Phase 1b trial in MSS metastatic colorectal cancer, evaluating TTX-080 in combination with cetuximab +...
Results, presented at ObesityWeek® 2025, showed patients receiving NG101 saw 40% reduction in nausea incidence and 67% reduction in vomiting...
Interim data from the IQIRVO® (elafibranor) ELATIVE long-term open label extension trial demonstrate sustained biochemical response, stabilization of fibrosis markers...
King of Prussia, Pennsylvania--(Newsfile Corp. - November 7, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 7, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
Doers Summit debuts in Dubai this November DUBAI, UAE, Nov. 7, 2025 /PRNewswire/ -- Doers Summit lands at Dubai Silicon Oasis...
Desiree Kameka Galloway and Danielle Vickers, who bring over 40 years of combined experience, will help propel the organization's mission...
As the only health-tech app designed specifically for GLP-1 users who dine out — and for restaurants eager to welcome...
The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one...
CHANDLER, Ariz., Nov. 6, 2025 /PRNewswire/ -- Raintree, the leading provider of AI-powered software solutions for rehabilitation and physical therapy organizations,...
SYDNEY, Nov. 6, 2025 /PRNewswire/ -- Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close...
Led by DRW and Liberty City Ventures, Transaction Cements Tharimmune as First Public Company to Deliver Canton-Aligned DAT Strategy Net...
KANSAS CITY, Mo., Nov. 6, 2025 /PRNewswire/ -- CarePortal, a Care-Sharing technology that drives action for local children and families...
WASHINGTON, Nov. 6, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people...
Q3 2025 financial results ahead of expectations. Announces more than $500 million in newly-contracted annualized revenue to launch in 2026....
After DOJ Concedes DEA's Courts Are Unconstitutional, MMJ BioPharma Cultivation's Fight for Patients Lands on President Trump's Desk WASHINGTON, DC...
MURFREESBORO, TN / ACCESS Newswire / November 6, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it will...
SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 6, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 6, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...
NEW BRUNSWICK, NEW JERSEY / ACCESS Newswire / November 6, 2025 / E&I Cooperative Services (E&I), the only member-owned, nonprofit...